Intervention Review

Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults

  1. Anna Holdgate1,*,
  2. Angeline Foo2

Editorial Group: Cochrane Heart Group

Published Online: 15 FEB 2012

Assessed as up-to-date: 20 JUL 2010

DOI: 10.1002/14651858.CD005154.pub3


How to Cite

Holdgate A, Foo A. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD005154. DOI: 10.1002/14651858.CD005154.pub3.

Author Information

  1. 1

    Liverpool Hospital, Emergency Medicine Research Unit, Liverpool, NSW, Australia

  2. 2

    St George Hospital, Department of Emergency Medicine, Kogarah, Australia

*Anna Holdgate, Emergency Medicine Research Unit, Liverpool Hospital, Sydney South West Area Health Service, Liverpool, NSW, 2170, Australia. Anna.holdgate@sswahs.nsw.gov.au.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 15 FEB 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.